The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 27, 2021

Filed:

Aug. 06, 2018
Applicants:

Hiroshima University, Higashihiroshima, JP;

Tokyo University of Pharmacy & Life Sciences, Hachioji, JP;

The University of Tokyo, Tokyo, JP;

Inventors:

Tomoichiro Asano, Hiroshima, JP;

Yusuke Nakatsu, Hiroshima, JP;

Hisanaka Ito, Hachioji, JP;

Takayoshi Okabe, Tokyo, JP;

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/19 (2006.01); A61K 31/415 (2006.01); A61K 31/5377 (2006.01); A61P 1/16 (2006.01); A61P 3/04 (2006.01); A61K 31/341 (2006.01); A61K 31/403 (2006.01); A61K 31/4184 (2006.01); A61K 31/4439 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 31/341 (2013.01); A61K 31/403 (2013.01); A61K 31/415 (2013.01); A61K 31/4184 (2013.01); A61K 31/4439 (2013.01); A61P 1/16 (2018.01); A61P 3/04 (2018.01); A61K 45/06 (2013.01);
Abstract

The purpose of the invention is to develop a novel therapeutic agent for fatty liver diseases such as NASH or NAFLD. The invention provides a therapeutic or prophylactic agent for fatty liver diseases that comprises, as an active ingredient, a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. The invention also provides a therapeutic or prophylactic agent for adiposity that comprises, as an active ingredient, a compound represented by formula (I) or a pharmaceutically acceptable salt thereof.


Find Patent Forward Citations

Loading…